Agreement: Page 2

Quest Diagnostics, Premier ink laboratory stewardship platform and services agreement
By LabPulse.com staff writers
Premier members can obtain specific negotiated pricing and terms to access Quest's laboratory stewardship solution.
December 1, 2022
Lab Biochemical Analyzer Social
KSL Pulse Scientific to distribute Lucira Health COVID, flu molecular test in Canada
By LabPulse.com staff writers
The test was approved by Health Canada and will be available to healthcare providers and consumers for the fall and winter COVID and flu season.
November 29, 2022
Influenza Virus Social
Bio-Rad Laboratories, NuProbe USA sign licensing agreement for digital PCR assays
By LabPulse.com staff writers
The agreement allows NuProbe to license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays
November 8, 2022
Digital Science Lab Social
Sense Biodetection signs distribution agreement with Biotecom for MDx platform
By LabPulse.com staff writers
The agreement allows Biotecom to provide Chilean hospitals, laboratories, and clinics with the Veros molecular testing platform.
November 2, 2022
Business Deal Corporate Social
QuantuMDx inks distribution agreement with Menarini
By LabPulse.com staff writers
According to the agreement, Menarini will handle the distribution and marketing of the Q-POC platform, COVID assay, and QuantuMDx’s SARS-CoV-2/Flu A/B/RSV Respiratory Panel test in the U.K. and France.
November 2, 2022
Global Collaboration Business Social
Shineco moves into point-of-care testing, inks stock purchase agreement with Chinese biotech
By LabPulse.com staff writers
The stock purchase agreement is an initiative in Shineco’s strategy aimed at moving into the point-of-care testing industry.
October 25, 2022
Business Handshake Man Social
Fujirebio Europe secures distribution rights for Self-Screen's methylation-specific molecular assay
By LabPulse.com staff writers
The test identifies women at high risk by detecting elevated methylation levels of cancer biomarkers, Fujirebio said, adding that it has been validated for both physician sample collection and sample self-collection.
October 11, 2022
Squamous Epithelial Cells Cervical
T2 Biosystems inks distribution agreement in Baltic region
By LabPulse.com staff writers
Under the terms of the agreement, the company will sell T2Dx Instruments, along with T2Bacteria, T2Candida, and T2Resistance panels, through an undisclosed distributor.
September 22, 2022
2020 06 19 20 57 0712 Sepsis Bacteria 400
Leuko nabs $5M for validation of WBC monitoring technology
By LabPulse.com staff writers
HTH VC, Good Growth Capital, IAG Capital Partners, Nina Capital, and angel investors provided the funding, Leuko said. The funding will allow the company to accelerate clinical trials with the aim of obtaining regulatory approval in collaboration with leading cancer centers, including the MD Anderson Cancer Center and Boston Medical Center in the U.S., and Dexeus and Hospital 12 de Octubre in Spain.
September 22, 2022
2021 01 08 22 20 9120 Cancer Cell Target2 400
Virax Biolabs inks distribution agreement for monkeypox kits
By LabPulse.com staff writers
Under the agreement, Cosmos will have exclusive distribution rights for Greece and Cyprus and can distribute the kits across Europe on a nonexclusive basis.
September 21, 2022
2019 04 24 17 43 1766 Hands Shaking2 400
S2 Genomics inks distribution agreement with Proteigene
By LabPulse.com staff writers
The partnership will expand the system's product line, leveraging Proteigene's customer-centric sales force and customer base, according to S2.
September 20, 2022
2020 01 08 21 29 8936 Dna Sequencing Sanger 400
Precipio announces agreement to promote HemeScreen platform
By LabPulse.com staff writers
The distributor focuses on a segment of the healthcare business which by Precipio's estimates represents an additional $100 million of market potential that its current distributors are less likely to reach.
September 15, 2022
2019 04 24 17 43 1766 Hands Shaking2 400
Previous Page
Page 2 of 16
Next Page